Trivago Chief Financial Officer Axel Hefer will replace co-founder and CEO Rolf Schrömgens at the end of the year, the company announced.
Hefer told Cheddar in an interview Tuesday the company had been working on a succession plan since he joined the company three years ago.
Schrömgens's co-founders Peter Vinnemeier and Stephan Stubner left the company in 2018. Hefer told Cheddar Schrömgens felt it was time for him "to move into a more passive role." Schrömgens will join the advisory board and give up his board of directors seat.
Trivago's stock was down about 19 percent after the surprising announcement, made along with the Q3 earnings report.
"Our third quarter overall came in softer than expected," he said. The company expects a smaller Q4 revenue than last year.
Hefer said the stock price reaction "is a combination of both filings and, obviously, very difficult to say which part of the drop is associated to the different news."
Hefer said the company has been focused on profitability after losing a "substantial sums of money" in the first half of 2018.
Smoke that filled the cabin of a Delta flight as it took off from the Atlanta airport in February was so thick the led flight attendant had trouble seeing past the first row of passengers and the pilots donned oxygen masks as a precaution.
Arjan Stephens, President of Nature's Path, discusses the company's origin, how it has evolved today and the interesting product that came from his wedding!
Small business reporter, Gene Marks, joins Cheddar to give analysis on how small businesses are tackling incoming tariffs and how it will affect the consumer.
Babylist CEO Natalie Gordon joins Cheddar to discuss how the website is helping new parents, how to make a registry and how secondhand options are available.
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection.
